{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/sore-throat-acute/prescribing-information/phenoxymethylpenicillin/","result":{"pageContext":{"chapter":{"id":"f21e5d05-51a3-5269-89a7-1cd1dfa352c1","slug":"phenoxymethylpenicillin","fullItemName":"Phenoxymethylpenicillin","depth":2,"htmlHeader":"<!-- begin field 3e60de32-dffe-4b74-85a2-5710e0240352 --><h2>Phenoxymethylpenicillin</h2><!-- end field 3e60de32-dffe-4b74-85a2-5710e0240352 -->","summary":"","htmlStringContent":"<!-- begin item 85f378fb-79ff-4b2d-87a2-03240f15caec --><!-- end item 85f378fb-79ff-4b2d-87a2-03240f15caec -->","topic":{"id":"b9203bc1-aec0-515e-b8a8-df5fbd75f255","topicId":"a235ee81-d6c7-4837-95b1-fc8ac97489f1","topicName":"Sore throat - acute","slug":"sore-throat-acute","lastRevised":"Last revised in January 2021","chapters":[{"id":"81404cee-5cce-5697-afc1-b29dbea3cf99","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"7b8dd3db-314e-5c48-8169-957babf68c00","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"3f5b8783-adcd-5d7a-9330-002285fe81e4","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"ecd64c56-4cd5-5be5-a040-00612d411a68","slug":"changes","fullItemName":"Changes"},{"id":"11abf9ad-d544-577d-a891-c5a379708aed","slug":"update","fullItemName":"Update"}]},{"id":"55736356-174b-57ec-a949-beb91d4a0588","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f4a572be-4b7a-5dd2-831f-2dd322766a65","slug":"goals","fullItemName":"Goals"},{"id":"7468eca7-2a8b-5d28-a756-280ec1cd0464","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2da6717d-60e3-58be-9fe4-0fc22ae6d4d7","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"d29c6cc4-23ef-5837-940d-d890d90aa33f","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"8818b707-787c-51f1-9007-fecb6a288a42","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"1e00743e-81b9-5ac8-b01f-4420d8c68b7f","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"39107ffb-18a4-5a9d-8131-c82505adb09c","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"d58cc01b-2d33-5685-91a3-e9d59574c64d","slug":"definition","fullItemName":"Definition"},{"id":"a6fba973-e2b5-5eb0-a063-1bb336822fd0","slug":"causes","fullItemName":"Causes"},{"id":"793adffe-ef81-5f79-ab01-6c897d35ec86","slug":"prevalence","fullItemName":"Prevalence"},{"id":"7d076a78-65a8-52bf-afc2-f4a0d24ce69b","slug":"complications","fullItemName":"Complications"},{"id":"7e75d866-d16d-54e5-abdc-52799a96b2fd","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"94a90a22-6b78-544b-98f0-8f49469d7022","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"a65f2b2d-ebde-518c-8aff-0bf46dde42ad","slug":"diagnosing-the-cause","fullItemName":"Diagnosing the cause"}]},{"id":"6b54d469-8077-579a-aad8-21a2ab946d6d","fullItemName":"Management","slug":"management","subChapters":[{"id":"a51c56c5-9d90-5194-8d4c-0433122f7ee8","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"5bc31f90-4751-5459-b9e5-7dbb124672e5","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"9e06b9f3-0d6a-5349-88a2-1a419eb8bbc7","slug":"paracetamol-ibuprofen","fullItemName":"Paracetamol and ibuprofen"},{"id":"d99bdb44-8580-5ebb-a68b-3a1e1f822b8e","slug":"clarithromycin-erythromycin","fullItemName":"Clarithromycin and erythromycin"},{"id":"f21e5d05-51a3-5269-89a7-1cd1dfa352c1","slug":"phenoxymethylpenicillin","fullItemName":"Phenoxymethylpenicillin"}]},{"id":"9c3bce6b-ef05-5894-b906-ebccbff4fff7","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"9642452f-8502-5e85-9e59-8aea1e5a9996","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"579fc7ee-bad3-53f9-a1f1-b2412d296c59","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"2807a9ce-d5d7-5d5b-9a3d-cb18d70b51a0","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"91281f6e-4047-5b51-8bfb-1db3fc6e5b25","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"3fadc0e8-a0b9-5471-b119-9c8264f2d302","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"243cf86e-53bf-5d72-8adc-a551dbece129","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"4f26f8fe-168a-5d87-8f26-59783d95e902","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"5bc31f90-4751-5459-b9e5-7dbb124672e5","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"0023b50e-30eb-5bb9-9b77-a4c846d8ae6f","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 2969ff7d-0d54-4682-ae06-a79b00b1cc43 --><h3>Contraindications and cautions</h3><!-- end field 2969ff7d-0d54-4682-ae06-a79b00b1cc43 -->","summary":"","htmlStringContent":"<!-- begin item dd7b8e51-e9eb-4916-941b-a79b00b1c83b --><!-- begin field e110e9d8-3b7c-4123-81a8-a79b00b1cc43 --><ul><li>Do not prescribe a penicillin to people with a history of anaphylaxis, urticaria, or rash immediately after penicillin administration due to risk of immediate hypersensitivity.<ul><li>Note: People with a history of a minor rash (i.e. non-confluent, non-pruritic rash restricted to a small area of the body), or a rash that occurs more than 72 hours after penicillin administration are probably not allergic to penicillin and in these individuals, a penicillin should not be withheld unnecessarily for serious infections.</li></ul></li><li>Prescribe penicillins with caution to people with a history of atopic allergy (e.g. asthma, eczema, hay fever) as these people are at increased risk of anaphylactic reactions.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sore-throat-acute/references/\">ABPI Medicines Compendium, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sore-throat-acute/references/\">BNF 73, 2017</a>]</p><!-- end field e110e9d8-3b7c-4123-81a8-a79b00b1cc43 --><!-- end item dd7b8e51-e9eb-4916-941b-a79b00b1c83b -->","subChapters":[]},{"id":"5d38e628-0c62-5d88-860a-cc6d2500a920","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 97aa2994-6612-4f9b-b931-a79b00b1e878 --><h3>Adverse effects</h3><!-- end field 97aa2994-6612-4f9b-b931-a79b00b1e878 -->","summary":"","htmlStringContent":"<!-- begin item c914f336-d01b-45aa-a1bc-a79b00b1e39c --><!-- begin field 2b023672-e281-406e-8457-a79b00b1e878 --><ul><li><strong>Common adverse effects of penicillins include:</strong><ul><li>Anaphylaxis.</li><li>Angioedema.</li><li>Diarrhoea — consider pseudomembranous colitis if a person develops severe diarrhoea during or after treatment with a penicillin. Pseudomembranous colitis is an acute, exudative colitis caused by Clostridium difficile, a Gram-positive toxin-releasing bacillus. It often follows antibiotic treatment. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diarrhoea-antibiotic-associated/\">Diarrhoea - antibiotic associated</a>.</li><li>Fever.</li><li>Hypersensitivity reactions.</li><li>Joint pain.</li><li>Rash.</li><li>Serum sickness-like reaction.</li><li>Urticaria.</li></ul></li><li><strong>Rarer adverse effects include:</strong><ul><li>Cerebral irritation.</li><li>CNS toxicity (including convulsions).</li><li>Coagulation disorders. </li><li>Encephalopathy.</li><li>Haemolytic anaemia. </li><li>Interstitial nephritis. </li><li>Leucopenia. </li><li>Thrombocytopenia.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sore-throat-acute/references/\">ABPI Medicines Compendium, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sore-throat-acute/references/\">BNF 73, 2017</a>]</p><!-- end field 2b023672-e281-406e-8457-a79b00b1e878 --><!-- end item c914f336-d01b-45aa-a1bc-a79b00b1e39c -->","subChapters":[]},{"id":"ca25baf1-5144-5aea-81b5-c1d811ea4b66","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field ef706ffd-a03d-4282-a2eb-a79b00b20723 --><h3>Drug interactions</h3><!-- end field ef706ffd-a03d-4282-a2eb-a79b00b20723 -->","summary":"","htmlStringContent":"<!-- begin item 6313fbc2-660a-4fc1-90e4-a79b00b202b4 --><!-- begin field 0d19cb2d-c714-4ad3-bba4-a79b00b20723 --><p><strong>Drug interactions with phenoxymethylpenicillin include:</strong></p><ul><li><strong>Neomycin</strong> — absorption of phenoxymethylpenicillin reduced.</li><li><strong>Courmarins</strong> — INR can be altered with current penicillin use. Consider monitoring INR and adjusting anticoagulant dose if necessary.</li><li><strong>Methotrexate</strong> — penicillins reduce excretion of methotrexate, leading to increased risk of toxicity. Consider dose adjustment.</li><li><strong>Sulfinpyrazone</strong> — excretion of penicillins reduced.</li><li><strong>Tetracyclines</strong> — effects of penicillins possibly antagonised by tetracyclines.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sore-throat-acute/references/\">ABPI Medicines Compendium, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sore-throat-acute/references/\">BNF 73, 2017</a>]</p><!-- end field 0d19cb2d-c714-4ad3-bba4-a79b00b20723 --><!-- end item 6313fbc2-660a-4fc1-90e4-a79b00b202b4 -->","subChapters":[]},{"id":"915cfb94-ee91-5fee-9f10-0ca86600a318","slug":"dosing-information","fullItemName":"Dosing information","depth":3,"htmlHeader":"<!-- begin field 7ad3a79b-ffbf-4b2d-bae7-a7c101745d75 --><h3>Dosing information</h3><!-- end field 7ad3a79b-ffbf-4b2d-bae7-a7c101745d75 -->","summary":"","htmlStringContent":"<!-- begin item 819a32db-86a2-4640-8924-a7c1017456d5 --><!-- begin field 7bd145bb-633d-49f4-89d1-a7c101745d75 --><ul><li>In adults, prescribe 500 mg four times daily, or 1 g twice daily (increased if necessary up to 1 g four times daily) for ten days.</li><li>In children, prescribe:<ul><li>62.5 mg four times daily, increased if necessary up to 12.5 mg/ kg four times daily in those aged 1 to 11 months.</li><li>125 mg four times daily, increased if necessary up to 12.5 mg/ kg four times daily in those aged 1 to 5 years.</li><li>250 mg four times daily, increased if necessary up to 12.5 mg/ kg four times daily in those aged 6 to 11 years.</li><li>500 mg four times daily, increased if necessary up to 1 g four times daily in those aged 12 to 17 years.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/sore-throat-acute/references/\">BNF 73, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/sore-throat-acute/references/\">PHE, 2017b</a>]</p><!-- end field 7bd145bb-633d-49f4-89d1-a7c101745d75 --><!-- end item 819a32db-86a2-4640-8924-a7c1017456d5 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}